PrOVE QUERI Project #1

Study summary

The overall goal of this project is to test two strategies for implementing a shared decision making tool to be used by providers while talking to patients about lung cancer screening. Eight participating sites will be randomized to compare standard implementation with intensive implementation. Additionally, the investigators will determine the factors that were most important for successful implementation of the shared decision making tool. Finally, the investigators will survey patients to evaluate the effects of Decision Precision on patient's knowledge of the risks and benefits of lung cancer screening, the quality of their decision making, and their satisfaction with care.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedWebinar, Promotion, and Tool Access and LEAP

Plus 2 other study approaches.

Who it may be forPrevention and Control

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 31, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?8 U.S. locations

Locations may change over time.

Who runs it?VA Office of Research and Development

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: VA Office of Research and Development
Interventions being studied: Other: Webinar, Promotion, and Tool Access; Other: LEAP; Other: Audit and Feedback; Other: Academic Detailing

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients at participating sites without documented exclusions for lung cancer screening who have had initial lung cancer screening clinical reminders resolved during the recruitment period

Reasons someone may not be able to joinExclusion criteria

Exclusions for initial lung cancer screening clinical reminders:
history of lung, pancreatic, liver or esophageal cancer
a health factor on file indicating they have a life expectancy of less than 6 months or who already had a chest CT in the past 12 months

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

VA Ann Arbor Healthcare System, Ann Arbor, MIAnn Arbor, Michigan
Minneapolis VA Health Care System, Minneapolis, MNMinneapolis, Minnesota
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NYNew York, New York
Durham VA Medical Center, Durham, NCDurham, North Carolina
Cincinnati VA Medical Center, Cincinnati, OHCincinnati, Ohio
VA Portland Health Care System, Portland, ORPortland, Oregon
Providence VA Medical Center, Providence, RIProvidence, Rhode Island
Ralph H. Johnson VA Medical Center, Charleston, SCCharleston, South Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 31, 2024. Always confirm current availability with the study team.

View original record ↗